Figure S15 from Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti–PD-1 Immunotherapy

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Results of the therapy with the depleting anti-IL1R2 Nb-Fc construct 3 or the SDALIE-mutated, ADCC-enhanced construct 3, as monotherapy or in combination with anti–PD-1 mAb, in E0771 and MC38 tumor-bearing mice